Short-term and long-term outcomes of laparoscopic vs open ileocolic resection in patients with Crohn's disease: Propensity-score matching analysis

BACKGROUND Laparoscopic ileocolic resection (LICR) is the preferred surgical approach for primary ileocolic Crohn’s disease (CD) because it has greater recovery benefits than open ICR (OICR). AIM To compare short- and long-term outcomes in patients who underwent LICR and OICR. METHODS Patients who underwent ICR for primary CD from 2006 to 2017 at a single tertiary center specializing in CD were included. Patients who underwent LICR and OICR were subjected to propensity-score matching analysis. Patients were propensity-score matched 1:1 by factors potentially associated with 30-d perioperative morbidity. These included demographic characteristics and disease- and treatment-related variables. Factors were compared using univariate and multivariate analyses. Long-term surgical recurrence-free survival (SRFS) in the two groups was determined by the Kaplan-Meier method and compared by the log-rank test. RESULTS During the study period, 348 patients underwent ICR, 211 by the open approach and 137 laparoscopically. Propensity-score matching yielded 102 pairs of patients. The rate of postoperative complication was significantly lower (14% versus 32%, P = 0.003), postoperative hospital stay significantly shorter (8 d versus 13 d, P = 0.003), and postoperative pain on day 7 significantly lower (1.4 versus 2.3, P < 0.001) in propensity-score matched patients who underwent LICR than in those who underwent OICR. Multivariate analysis showed that postoperative complications were significantly associated with preoperative treatment with biologics [odds ratio (OR): 3.14, P = 0.01] and an open approach to surgery (OR: 2.86, P = 0.005). The 5- and 10-year SRFS rates in the matched pairs were 92.9% and 83.3%, respectively, with SRFS rates not differing significantly between the OICR and LICR groups. The performance of additional procedures was an independent risk factor for surgical recurrence [hazard ratio (HR): 3.28, P = 0.02]. CONCLUSION LICR yielded better short-term outcomes and postoperative recovery than OICR, with no differences in long-term outcomes. LICR may provide greater benefits in selected patients with primary CD.

[1]  H. Ikeuchi,et al.  Does anti‐tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta‐analysis , 2020, Journal of gastroenterology and hepatology.

[2]  Yousheng Li,et al.  Previous Intestinal Resection Is Associated with Postoperative Complications in Crohn's Disease: A Cohort Study , 2020, Gastroenterology research and practice.

[3]  Jiancong Hu,et al.  Laparoscopic Surgery for Complex Crohn's Disease: A Meta-Analysis. , 2019, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[4]  E. El Rassy,et al.  Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn’s Disease , 2019, Journal of clinical gastroenterology.

[5]  J. Feuerstein,et al.  Surgery in the age of biologics , 2019, Gastroenterology report.

[6]  D. Mège,et al.  Laparoscopy in Crohn Disease: Learning Curve and Current Practice. , 2020, Annals of surgery.

[7]  C. Yu,et al.  Current Status and Trends in Inflammatory Bowel Disease Surgery in Korea: Analysis of Data in a Nationwide Registry , 2018, Annals of coloproctology.

[8]  Weiming Zhu,et al.  Frequency and risk factors of surgical recurrence of Crohn's disease after primary bowel resection. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[9]  J. Monson,et al.  Ileocolic Resection for Crohn's Disease: A Minimally Invasive Approach Claims Its Place , 2018, The American surgeon.

[10]  J. Santos,et al.  Risk factors for postoperative complications in Crohn disease: analysis of 173 patients , 2018, Journal of Coloproctology.

[11]  W. Sandborn,et al.  Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience , 2018, Inflammatory bowel diseases.

[12]  Jana G Hashash,et al.  A comprehensive review and update on Crohn's disease. , 2017, Disease-a-month : DM.

[13]  C. Yu,et al.  Does Anastomosis Configuration Influence Long-term Outcomes in Patients With Crohn Disease? , 2017, Annals of coloproctology.

[14]  C. Buskens,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.

[15]  F. Carbonnel,et al.  Preoperative oral polymeric diet enriched with transforming growth factor-beta 2 (Modulen) could decrease postoperative morbidity after surgery for complicated ileocolonic Crohn’s disease , 2017, Scandinavian journal of gastroenterology.

[16]  S. Danese,et al.  Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study , 2016, United European gastroenterology journal.

[17]  M. Mittlböck,et al.  Minimal-invasive approach for penetrating Crohn’s disease is not associated with increased complications , 2016, Surgical Endoscopy.

[18]  Jianan Ren,et al.  Laparoscopy improves clinical outcome of gastrointestinal fistula caused by Crohn's disease. , 2016, The Journal of surgical research.

[19]  V. Tsikitis,et al.  Trends in the Surgical Management of Crohn’s Disease , 2015, Journal of Gastrointestinal Surgery.

[20]  I. Kristo,et al.  Surgical recurrence in Crohn's disease: Are we getting better? , 2015, World journal of gastroenterology.

[21]  Yifan Sun,et al.  Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies. , 2015, Journal of Crohn's & colitis.

[22]  Xiaojian Wu,et al.  Stapled Side-to-Side Anastomosis Might Be Better Than Handsewn End-to-End Anastomosis in Ileocolic Resection for Crohn’s Disease: A Meta-Analysis , 2014, Digestive Diseases and Sciences.

[23]  Y. Panis,et al.  Laparoscopy in Crohn's disease. , 2014, Best practice & research. Clinical gastroenterology.

[24]  Sanjay V. Patel,et al.  Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery , 2013, BMC Surgery.

[25]  E. Rijcken,et al.  Current status of laparoscopic surgery for patients with Crohn’s disease , 2013, International Journal of Colorectal Disease.

[26]  L. Beyer-Berjot,et al.  Laparoscopic Approach Is Feasible in Crohn’s Complex Enterovisceral Fistulas: A Case-Match Review , 2013, Diseases of the colon and rectum.

[27]  Weiming Zhu,et al.  Comparing Outcomes Between Side-to-Side Anastomosis and Other Anastomotic Configurations After Intestinal Resection for Patients with Crohn’s Disease: A Meta-Analysis , 2013, World Journal of Surgery.

[28]  W. Sandborn,et al.  Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry , 2012, The American Journal of Gastroenterology.

[29]  F. Fleming,et al.  A laparoscopic approach reduces short‐term complications and length of stay following ileocolic resection in Crohn’s disease: an analysis of outcomes from the NSQIP database , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[30]  C. Yu,et al.  Clinical features and long-term prognosis of Crohn's disease in Korea , 2010, Scandinavian journal of gastroenterology.

[31]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[32]  D. Gouma,et al.  Laparoscopic-assisted vs open ileocolic resection for Crohn’s disease , 2000, Surgical Endoscopy.

[33]  S. Wexner,et al.  Laparoscopic surgery for inflammatory bowel disease: does weight matter? , 2009, Surgical Endoscopy.

[34]  V. Fazio,et al.  Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. , 2008, Surgery.

[35]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[36]  W. Sandborn,et al.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  D. Gouma,et al.  Laparoscopic-Assisted Versus Open Ileocolic Resection for Crohn's Disease: A Randomized Trial , 2006, Annals of surgery.

[38]  A. Rosman,et al.  Metaanalysis of trials comparing laparoscopic and open surgery for Crohn’s disease , 2005, Surgical Endoscopy And Other Interventional Techniques.

[39]  N. Scott,et al.  Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection , 2004, International Journal of Colorectal Disease.

[40]  T. Hibi,et al.  Laparoscopic surgery for recurrent Crohn's disease , 2003, The British journal of surgery.

[41]  O Bernell,et al.  Risk factors for surgery and postoperative recurrence in Crohn's disease. , 2000, Annals of surgery.

[42]  M. Keighley,et al.  Strategy for Surgical Management of Ileocolonic Anastomotic Recurrence in Crohn's Disease , 1999, World Journal of Surgery.

[43]  M. Keighley,et al.  Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. , 1999, Scandinavian journal of gastroenterology.